Company: IPCX
Filing Date: 2025-04-08
Form Type: S-1/A
Source: 0001213900-25-029998
Chunk: 156

Company: Inflection Point Acquisition Corp. III
Filing Date: 2025-04-08
Form: S-1/A
Chunk 156
---
  (6,325,000 | ) |     |                |  (11,000,000 | ) |     |            |  (12,650,000 | ) |     |                |  (16,500,000 | ) |     |            |  (18,975,000 | ) |     |                     |  (22,000,000 | ) |     |            |  (25,300,000 | ) |
|                                                                                                   |     |                |  32,347,333 |   |     |            |  37,077,333 |   |     |                |  26,847,333 |   |     |            |  30,752,333 |   |     |                |   21,347,333 |   |     |            |   24,427,333 |   |     |                |   15,847,333 |   |     |            |   18,102,333 |   |     |                     |   10,347,333 |   |     |            |   11,777,333 |   |

____________ (1)Expenses applied against gross proceeds include offering expenses of approximately $750,000 and underwriting commissions of $4,400,000. See “ Use of Proceeds.”

97

(2)Upon the closing of this offering, $0.20 per unit, will be payable to Cantor Fitzgerald & Co. In addition, $0.45 per unit on units other than those sold pursuant to the underwriters’ option to purchase additional units and $0.65 per unit on units sold pursuant to the underwriters’ option to purchase additional units, or $9,900,000 in the aggregate if the underwriters’ over -allotmentoption is not exercised or up to $12,045,000 in the aggregate if the underwriters’ over -allotmentoption is exercised in full, will be payable to Cantor Fitzgerald & Co. for deferred underwriting commissions and will be placed in a trust account located in the United States as described herein. The deferred commissions will be fully earned by the underwriters upon the payment of the purchase price for the units purchased by the underwriters on the closing of this offering and will be released to the underwriters only on and concurrently with completion of an initial business combination. (3)If we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection